Alliance Pharma (APH)

Company name:Alliance Pharma Plc
EPIC:APHTrading Currency:GBX
Market Sector:AS50ISIN:GB0031030819
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 79.10 3.3 [4.35] 77.20 79.20 78.00 80.90 76.40 1,752,120
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 410.97 519.56 0.03 3.69 1.47 21.44 1.86 82.40 - 59.20

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.410.97m
Shares In Issue519.56m
Prev. Close75.80
PE Ratio21.44 
Dividend Yield1.86%
EPS - basic3.69p
Dividend PS1.47p
Dividend Cover2.51 
Cash Flow PS4.27p
Return On Equity (ROE)7.28%
Operating Margin19.29%
PEG Factor-0.54 
EPS Growth Rate-39.51%
Dividends PS Growth Rate10.53%
Net Debt140.52m
Gross Gearing37.51%
Quick Assets41.89m
Net Working Capital-31.13m
Intangibles / Fixed Assets97.73%
Turnover PS22.75p
Pre-Tax Profit PS4.39p
Retained Profit PS2.31p
Cash PS2.10p
Net Cash PS-15.56p
Net Tangible Asset Value PS *-15.98p
Net Asset Value PS48.54p
Spread2.00 (2.53%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week80.9075.40
4 weeks81.9070.60
12 weeks81.9066.60
1 year82.4059.20

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week78.001.101.4175.400.5678.19
4 weeks73.805.307.1870.600.9778.09
12 weeks67.3011.8017.5366.601.1874.83
26 weeks76.202.903.8164.300.9372.69
1 year66.0013.1019.8559.200.8571.56
3 years44.7534.3576.7644.751.0970.15
5 years32.8846.23140.6132.880.8365.20

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio109.10 
PE Ratio21.44 
Tobin's Q Ratio 1.11 
Tobin's Q Ratio (excl. intangibles)6.51 
Dividend Yield1.86%
Market-to-Book Ratio1.63 
Price-to-Pre-Tax Profit PS18.02 
Price-to-Retained Profit PS34.22 
Price-to-Cash Flow PS18.54 
Price-to-Sales PS3.48 
Price-to-Net Tangible Asset Value PS-4.95 
Price-to-Cash PS37.73 
Net Working Capital PS-5.99 
Price Pct to Working Capital PS-13.20%
Earnings Yield4.66%
Average PE12.49 
Years in average5 
PE to PE average171.62%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio19.14%
Debt-to-Equity Ratio0.24 
Debt-to-Equity Ratio (excl. Intgbl)-0.72 
Debt-to-Equity Market Value0.15 
Net Gearing34.82%
Net Gearing (excl. Intangibles)205.54%
Gross Gearing37.51%
Gross Gearing (excl. Intangibles)221.47%
Gearing Under 1 Year22.73%
Gearing Under 1 Year (excl. Intgbl)134.16%
(Liquidity Ratios)
Net Working Capital to Total Assets-7.71%
Current Ratio0.66 
Quick Ratio (Acid Test)0.46 
Liquidity Ratio0.12 
Cash & Equiv/Current Assets17.98%
(Solvency Ratios)
Enterprise Value459.76m
CFO/Attributable Profit1.21 
Total Debt/Equity Market Value0.37 
Total Debt/Sales1.28 
Total Debt/Pre-Tax Profit6.64 
Total Debt151.41m
Total Debt/Net Current Assets-4.86%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth3.08%
10 yr Compound Earnings Growth4.53%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)7.31%
Return On Assets (ROA)4.96%
Net Profit Margin15.53%
Assets Turnover0.32 
Return On Equity (ROE)7.28%
Return On Investment (ROI)6.25%
Dividend Payout Ratio39.84%
Plowback Ratio60.16%
Growth from Plowback Ratio4.85%
Net Income Of Revenues10.16%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.52 
Fixed Assets Turnover0.38 
Current Assets Turnover2.09 
Net Working Capital Turnover 
Inventory Turnover7.17 
(Other Operating Ratios)
Total Assets-to-Sales3.13 
Debt Collection Period90.05Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
26 Mar 2019FinalGBX0.9831/12/201731/12/201813/06/201914/06/201911/07/20191.47
19 Sep 2018InterimGBX0.4931/12/201731/12/201820/12/201821/12/201810/01/2019-
27 Mar 2018FinalGBX0.8931/12/201631/12/201714/06/201815/06/201811/07/20181.33
13 Sep 2017InterimGBX0.4431/12/201631/12/201721/12/201722/12/201711/01/2018-
29 Mar 2017FinalGBX0.8131/12/201531/12/201615/06/201716/06/201712/07/20171.21
14 Sep 2016InterimGBX0.4031/12/201531/12/201622/12/201623/12/201612/01/2017-
07 Apr 2016FinalGBX0.7431/12/201431/12/201516/06/201617/06/201613/07/20161.10
09 Sep 2015InterimGBX0.3631/12/201431/12/201524/12/201529/12/201514/01/2016-
25 Mar 2015FinalGBX0.6731/12/201331/12/201418/06/201519/06/201515/07/20151.00
10 Sep 2014InterimGBX0.3331/12/201331/12/201403/12/201405/12/201415/01/2015-
26 Mar 2014FinalGBX0.6131/12/201231/12/201311/06/201413/06/201410/07/20140.91
11 Sep 2013InterimGBX0.3031/12/201231/12/201304/12/201306/12/201315/01/2014-
21 Mar 2013FinalGBX0.5531/12/201131/12/201212/06/201314/06/201311/07/20130.83
12 Sep 2012InterimGBX0.2831/12/201131/12/201205/12/201207/12/201215/01/2013-
22 Mar 2012FinalGBX0.5031/12/201031/12/201113/06/201215/06/201212/07/20120.75
07 Sep 2011InterimGBX0.2531/12/201031/12/201130/11/201102/12/201113/01/2012-
23 Mar 2011FinalGBX0.4031/12/200931/12/201015/06/201117/06/201114/07/20110.57
08 Sep 2010InterimGBX0.1731/12/200931/12/201001/12/201003/12/201014/01/2011-
24 Mar 2010FinalGBX0.2331/12/200831/12/200916/06/201018/06/201015/07/20100.30
09 Sep 2009InterimGBX0.0730/12/200830/06/200902/12/200904/12/200915/01/2010-

Alliance Pharma Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
pre tax profit15.1831.40%22.2222.79%28.3727.46%22.8019.29%m
attributable profit12.6926.25%18.0918.56%28.9127.98%18.3615.53%m
retained profit10.0520.79%12.9413.27%23.1822.44%12.0110.16%m
eps - basic (p)4.65 3.85 6.10 3.69 
eps - diluted (p)4.55 3.82 6.03 3.60 
dividends per share1.10 1.21 1.33 1.47 

Alliance Pharma Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
fixed assets fixed assets1.010.35%1.810.56%3.381.00%7.591.88%m
intangibles intangibles259.9488.96%264.8382.57%278.6282.81%335.2483.06%m
fixed investments fixed investments1.590.54%1.640.51%1.710.51%0.180.04%m
current assets - other current assets - other--%--%--%--%m
stocks stocks12.914.42%15.364.79%14.254.23%18.714.63%m
debtors debtors13.514.62%29.889.32%27.338.12%30.997.68%m
cash & securities cash & securities3.231.11%7.222.25%11.183.32%10.892.70%m
creditors - short creditors - short31.7610.87%50.2815.68%60.8118.07%91.7222.73%m
creditors - long creditors - long98.0033.54%91.2028.43%72.2921.48%59.6914.79%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves162.4455.59%179.2655.89%203.3860.44%252.2062.49%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF7.9816.9326.5822.17m
Pre-Financing CF-126.398.9010.67-36.91m
Retained CF2.093.434.22-0.33m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191215 12:39:54